Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?

Benzer Materyaller

• Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
  Yazar:: Rees, MG, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
  Yazar:: Rees, MG, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
  Yazar:: Gloyn, A
  Baskı/Yayın Bilgisi: (2003)
• A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
  Yazar:: Matthew G Rees, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-01-01)
• Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
  Yazar:: Gloyn, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)